| Project/Area Number |
23791855
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
MURAKAMI ISAO 慶應義塾大学, 医学部, 共同研究員 (70445237)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | ヒトパピローマウイルス / メチル化 / エピジェネティックス / バイオマーカー |
|---|
| Research Abstract |
We investigated the correlation between methylation status in the L1 gene and the long control region (LCR) of HPV52/58 and CIN. The increased methylation at the CpG sites in the HPV52/58 L1 gene was correlated with the severity of cervical neoplasia. These data suggest that HPV methylation status of the L1 gene is a candidate biomarker of CIN for detecting CIN2 and CIN3.
The elucidation of antitumor immunity in CIN lesion is important for the elucidation of carcinogenic mechanism in cervical cancer. We investigated associations with the results of cytodiagnosis and HPV infection. It appeared that GM-CSF expression increased with lesion progression in the CIN cases, and the results suggested that host antitumor immune response was induced. On the other hand, MCP-1 expression decreased with lesion progression in the CIN cases, and the results suggested that immune escape developed, and that may be correlation with the progression in the CIN.
|
